A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2004
10/13/2004	CN1537003A Pharmaceutical composition comprising tricyclic compound for prevention or treatment of skin diseases
10/13/2004	CN1537002A Novel theterocyclic analogs of diphenylethylene compounds
10/13/2004	CN1537000A Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists
10/13/2004	CN1536988A Sustained-release delivery system
10/13/2004	CN1535968A Tetrahydro pyridyl or pyridyl heterocycle derivative
10/13/2004	CN1535957A New isoquinoline compounds, their preparation method and medicine composition contaning them
10/13/2004	CN1535728A Drug composition for curing disease produced from IL-6
10/13/2004	CN1535727A Mixed polypeptide vaccine, its preparation and application
10/13/2004	CN1535722A Colostrum peptide and its application
10/13/2004	CN1535686A Slowly-released preparation containing loratadine and pseudoephedrine sulfate and its preparation method
10/13/2004	CN1535622A Processing process for making beverage and food by using duck wheat as raw material
10/13/2004	CN1170849C Connective tissue growth factor fragments and methods and uses thereof
10/13/2004	CN1170823C [5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinyl amino] acetamide derivatives, process for producing the same, medicinal compositions the same and internediate of these compounds
10/13/2004	CN1170592C New use of melagatran
10/13/2004	CN1170560C Health care medical tea and production method thereof
10/13/2004	CN1170541C Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors
10/13/2004	CN1170538C Farnesyl protein transferase inhibitors for treating arthropathies
10/12/2004	US6803455 Inhibitors of nucleoside metabolism
10/12/2004	US6803364 Il-5 inhibiting 6-azauracil derivatives
10/12/2004	US6803362 Heterocyclic compounds
10/12/2004	US6803211 Cancer therapy
10/12/2004	US6803042 Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides
10/12/2004	US6803039 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM
10/12/2004	US6803031 Aerosol comprises particles comprising at least 10 percent by weight of an erectile dysfunction drug, such as sildenafil, tadalafil or vardenafil.
10/07/2004	WO2004085477A1 Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity
10/07/2004	WO2004085423A1 Piperidine derivatives for the treatment of chemokine or h1 mediated disease state
10/07/2004	WO2004085388A2 Cyclic protein tyrosine kinase inhibitors
10/07/2004	WO2004085373A1 Novel shogaol compound and tyrosinase activity inhibitor comprising the compound
10/07/2004	WO2004084942A2 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18)
10/07/2004	WO2004084931A1 Use of chemokine receptor agonists for stem cell transplantation
10/07/2004	WO2004084922A1 Infection inhibitor for fishes and shellfishes
10/07/2004	WO2004084918A1 Antipruritic composition for external use on skin
10/07/2004	WO2004084913A1 Use of n-acetyl-d-aminoglycosamine in treatment of local lesions or systematic symptoms related to autoimmune reactions
10/07/2004	WO2004084891A1 Methods for treating inflammatory conditions or inhibiting jnk
10/07/2004	WO2004084837A2 Methods and compositions for treating and preventing inflammatory conditions
10/07/2004	WO2004084822A2 Methods for inducing immune tolerance
10/07/2004	WO2004073728A3 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
10/07/2004	WO2004067568A3 Human il-1 beta antagonists
10/07/2004	WO2004064852B1 Standardised steroid saponin mixture, a method of its obtaining and application
10/07/2004	WO2004054514A3 C-6 modified indazolylpyrrolotriazines
10/07/2004	WO2004021999A3 Use of histamine h4 receptor modulators for the treatment of allergy and asthma
10/07/2004	WO2004007709A3 Production of polyketides
10/07/2004	WO2003099195A3 Immunomodulatory compounds and methods of use thereof
10/07/2004	WO2003057725A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
10/07/2004	WO2003053973A8 Pyrazolyl-substituted triazoloquinoxalines
10/07/2004	WO2003049679A3 Mitotic kinesin inhibitors
10/07/2004	WO2002088317A3 Fusion molecules and methods for treatment of immune diseases
10/07/2004	US20040198980 Selective rxr ligands
10/07/2004	US20040198978 for treating autoimmune diseases selected from psoriasis, multiple sclerosis and rheumatoid arthritis; N-(3-oxoundecanoyl)-L-homoserine lactone (OuDHL) and 2-n-heptyl-3-hydroxy-4(1H)-quinolone for example
10/07/2004	US20040198961 Fce fusion proteins for treatment of allergy and asthma
10/07/2004	US20040198834 Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions
10/07/2004	US20040198824 enzyme inhibitor; anticancer agents; analgesics; vision defects
10/07/2004	US20040198819 Intensifier for anticancer, antitumor agents; mixture of 3-hydroxybutyric acid, lactic acid, acetic acid, creatinine, carnitine, taurine, choline and urea
10/07/2004	US20040198781 Carbonic anhydrase inhibitor
10/07/2004	US20040198766 Chemical compounds
10/07/2004	US20040198757 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
10/07/2004	US20040198749 Methods of using sodium channel blockers
10/07/2004	US20040198748 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders
10/07/2004	US20040198737 Azaindoles
10/07/2004	US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
10/07/2004	US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
10/07/2004	US20040198716 Cysteine protease inhimbitors
10/07/2004	US20040198696 Agent and food for inhibiting IgE antibody
10/07/2004	US20040198689 Ribozyme sequences related to hiv resistance
10/07/2004	US20040198688 for treatment of atopic conditions (dermatitis, allergies); point mutations
10/07/2004	US20040198686 Administering resistin-like molecules alpha or beta
10/07/2004	US20040198677 macrolide and steroidal or non-steroidal substructures connected by an alkyl linker; esterification or amidation to couple; antiarthritic, antiasthmatic agents, nasal, gastrointestinal, dermatological and opthalmic disorders; veterinary or human therapy
10/07/2004	US20040198651 Secreted proteins
10/07/2004	US20040198645 Pharmaceutical compositions
10/07/2004	US20040197876 Recombinant fusion proteins and the trimers thereof
10/07/2004	US20040197872 can be used in single or dual purpose and porcine reproductive respiratory syndrome virus vector vaccines; genetic engineering
10/07/2004	US20040197869 including siderophore receptor polypeptides and porins from gram negative microbes, and preferably, lipopolysaccarhide at a concentration of no greater than about 10.0 endotoxin units per milliliter
10/07/2004	US20040197847 High throughput screening assays using fatty acid synthetic enzymes
10/07/2004	US20040197786 Method of examining steroid resnponsiveness
10/07/2004	US20040197427 Herbal composition for improving anticancer activity, immune response and hematopoiesis of the body, and protecting the body from oxidative damage, and the method of preparing the same
10/07/2004	US20040197409 a prosthetic device (sleeve) placed on the outside surface of the vessel or graft which then elutes antiproliferative drugs or agents from a drug-eluting matrix material; flexible, cylindrical, bioabsorbing, agent-eluting matrix with a vascular-sized lumen
10/07/2004	US20040197350 Immunizing compositions and methods of use
10/07/2004	US20040197349 Methods and reagents for vaccination which generate a CD8 T cell immune response
10/07/2004	US20040197346 Materials and methods for intracellular transport and their uses
10/07/2004	US20040197345 Prostate derived Ets factor
10/07/2004	US20040197341 Therapeutic process for p. aeruginosa infections using macrolide antibiotics
10/07/2004	US20040197335 Non-myeloablative tolerogenic treatment with tyrphostins
10/07/2004	US20040197327 Administering antagonist of receptor on surface of lymphocytes; therapy for multiple sclerosis; antidiabetic agents
10/07/2004	US20040197316 Novel method for the treatment of systemic lupus erythematosus
10/07/2004	US20040197307 Mixture of human interferons
10/07/2004	US20040197303 For therapy of inflammation and diseases or conditions associated with autoimmune responses
10/07/2004	US20040197289 Kind of oligosaccharides, their sulfates and dendrimers, and the uses of these compounds
10/07/2004	CA2731275A1 Tumour-associated peptides binding to mhc-molecules
10/07/2004	CA2520443A1 Methods for treating inflammatory conditions or inhibiting jnk
10/07/2004	CA2519920A1 Use of chemokine receptor agonists for stem cell transplantation
10/07/2004	CA2519313A1 Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity
10/07/2004	CA2519114A1 Methods and compositions for treating and preventing inflammatory conditions
10/07/2004	CA2518792A1 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18)
10/06/2004	EP1464330A1 Use of a composition containing oligosaccharides in combination with a saponine or a basic aminoacid, for topical administration or for inhalation
10/06/2004	EP1463820A1 Method of screening compounds
10/06/2004	EP1463817A2 Histamine receptor h3 polynucleotides
10/06/2004	EP1463806A2 Novel cyclooxygenase variants and methods of use
10/06/2004	EP1463803A2 Hematopoietic cells from human embryonic stem cells
10/06/2004	EP1463799A2 Methods for the induction of professional and cytokine-producing regulatory cells
10/06/2004	EP1463797A2 Methods of kidney transplantation utilizing developing nephric tissue

1 ... 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 ... 1172